Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Semaglutide and Tirzepatide cannot be prescribed to anyone with the following conditions and should not be purchased: BMI under 26, Gastroparesis (paralysis of your intestines), Triglycerides over 600 at any point, Pancreatic cancer, Pancreatitis, Type 1 diabetes, Hypoglycemia (low blood sugar), Insulin-dependent diabetes, Thyroid cancer, Family history of thyroid cancer, Personal or family history of Multiple Endocrine Neoplasia (MEN-2) syndrome, Anorexia or bulimia, Current symptomatic gallstones, Drug or alcohol abuse, Recent bariatric surgery, Diabetic retinopathy, current pregnancy or breastfeeding, plans to become pregnant, or history of allergic reaction to Semaglutide or Tirzepatide
GLP-1 agonists slow gastric emptying, which affects absorption timing for oral medications
Some compounding pharmacies add it to semaglutide formulations to enhance fat metabolism alongside the appetite suppression and metabolic effects of the GLP-1 agonist itself
Research shows that IGF-1 promotes the anagen (growth) phase and inhibits the catagen (regression) transition
US$ 26.38
US$ 22.92
US$ 26.51
US$ 25.94
US$ 23.10
